Monday, June 8, 2026
ADVT 
National

Survey examines hesitancy in early vaccine rollout

Darpan News Desk The Canadian Press, 31 Aug, 2021 03:29 PM
  • Survey examines hesitancy in early vaccine rollout

A national survey suggests the vast majority of Canadians planned to get vaccinated against COVID-19 when the country's rollout began, but intentions were lower among certain demographics, including residents of Alberta and racialized communities.

The survey, led by researchers at Toronto's St. Michael's Hospital, was published online Tuesday in The Lancet Regional Health —Americas.

The survey asked more than 14,500 Canadians online between December 2020 and February 2021 if they intended to get vaccinated once they were eligible, with researchers identifying differences in participants by age, education, ethnicity, and home province.

Nine per cent of respondents overall said they did not intend to get vaccinated, with hesitancy highest in Alberta at 16 per cent, and Manitoba and Saskatchewan, both at 14 per cent.

Fifteen per cent of respondents who identified as Indigenous and 12 per cent of those identifying as racialized said they did not intend to get vaccinated.

Men were more hesitant than women overall — 11 per cent versus eight — and participants aged 40 to 59 had the lowest vaccination intention, with about 12 per cent reporting no intention to get vaccinated.

The survey suggested that education also factored into hesitancy, with 14 per cent of participants with a college education or less saying they did not intend to get vaccinated, compared to five per cent of respondents with a bachelor's degree or higher.

The study did not indicate whether intent translated into action, but researchers say they plan to answer that in the coming months.

They noted that 18 per cent of eligible Canadians had not yet received a COVID-19 vaccine dose by Aug. 27 — nearly twice the rate expected in the survey.

Researchers said the findings should encourage policymakers to target vaccine campaigns on the most reluctant groups, as well as those who said they planned to get a shot but did not.

The study was a collaboration between the Centre for Global Health Research at Unity Health Toronto, the University of Toronto and the Angus Reid Forum. Funding was provided by an unrestricted grant from Pfizer Global Medical Grants and Unity Health Toronto.

MORE National ARTICLES

PM should promise to avoid pandemic election: MPs

PM should promise to avoid pandemic election: MPs
The committee makes no similar call for opposition parties to promise not to trigger an election during the pandemic by voting non-confidence in the government.

PM should promise to avoid pandemic election: MPs

In-person gatherings important, says church lawyer

In-person gatherings important, says church lawyer
Chief Justice Christopher Hinkson said during a hearing on Tuesday people are still free to hold and express religious views and it's the safety of those who are gathering that's at issue.

In-person gatherings important, says church lawyer

One Arrested After Gasoline Poured On Tent, Occupants Threatened

One Arrested After Gasoline Poured On Tent, Occupants Threatened
The tent was occupied by a woman and her dog at the time of the incident. Patrol officers attended and located the suspect in Cecilia Ravine Park.

One Arrested After Gasoline Poured On Tent, Occupants Threatened

A look at the Oxford-AstraZeneca vaccine

A look at the Oxford-AstraZeneca vaccine
On the one hand, Health Canada says Oxford-AstraZeneca’s vaccine has been deemed safe for seniors and points to emerging real-world data that shows it can protect older citizens against symptomatic infection.

A look at the Oxford-AstraZeneca vaccine

5.6M in funding for drug-dispensing machines

5.6M in funding for drug-dispensing machines
The machines, called MySafe, are similar to ATMs and allow drug users at risk of overdose to get hydromorphone pills dispensed to them after their palm has been scanned.

5.6M in funding for drug-dispensing machines

Ontario waits for guidance as B.C. delays 2nd dose

Ontario waits for guidance as B.C. delays 2nd dose
Alberto Martin, a University of Toronto immunology professor, says a published clinical trial showed the first dose of the Pfizer-BioNTech vaccine provided 60 per cent protection, but B.C. may have access to new or unpublished data.

Ontario waits for guidance as B.C. delays 2nd dose